Advancements in nano-enabled therapeutics for neuroHIV management

Ajeet Kaushik, Rahul Dev Jayant, Madhavan Nair Center for Personalized NanoMedicine, Institute of NeuroImmune Pharmacology, Department of Immunology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA Abstract: This viewpoint is a global call to promote fundamen...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kaushik A, Jayant RD, Nair M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	Nano-therapeutics personalized nanomedicine smart monitoring analytical systems HIV diseases management Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/9f66dc9ebf1c45208e52cf850ab7fd76
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:9f66dc9ebf1c45208e52cf850ab7fd76
record_format	dspace
spelling	oai:doaj.org-article:9f66dc9ebf1c45208e52cf850ab7fd762021-12-02T05:08:58ZAdvancements in nano-enabled therapeutics for neuroHIV management1178-2013https://doaj.org/article/9f66dc9ebf1c45208e52cf850ab7fd762016-09-01T00:00:00Zhttps://www.dovepress.com/advancements-in-nano-enabled-therapeutics-for-neurohiv-management-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Ajeet Kaushik, Rahul Dev Jayant, Madhavan Nair Center for Personalized NanoMedicine, Institute of NeuroImmune Pharmacology, Department of Immunology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA Abstract: This viewpoint is a global call to promote fundamental and applied research aiming toward designing smart nanocarriers of desired properties, novel noninvasive strategies to open the blood–brain barrier (BBB), delivery/release of single/multiple therapeutic agents across the BBB to eradicate neurohuman immunodeficiency virus (HIV), strategies for on-demand site-specific release of antiretroviral therapy, developing novel nanoformulations capable to recognize and eradicate latently infected HIV reservoirs, and developing novel smart analytical diagnostic tools to detect and monitor HIV infection. Thus, investigation of novel nanoformulations, methodologies for site-specific delivery/release, analytical methods, and diagnostic tools would be of high significance to eradicate and monitor neuroacquired immunodeficiency syndrome. Overall, these developments will certainly help to develop personalized nanomedicines to cure HIV and to develop smart HIV-monitoring analytical systems for disease management. Keywords: nanotherapeutics, personalized nanomedicine, smart monitoring analytical systems, HIV disease managementKaushik AJayant RDNair MDove Medical PressarticleNano-therapeuticspersonalized nanomedicinesmart monitoring analytical systemsHIV diseases managementMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 11, Pp 4317-4325 (2016)
institution	DOAJ
collection	DOAJ
language	EN
topic	Nano-therapeutics personalized nanomedicine smart monitoring analytical systems HIV diseases management Medicine (General) R5-920
spellingShingle	Nano-therapeutics personalized nanomedicine smart monitoring analytical systems HIV diseases management Medicine (General) R5-920 Kaushik A Jayant RD Nair M Advancements in nano-enabled therapeutics for neuroHIV management
description	Ajeet Kaushik, Rahul Dev Jayant, Madhavan Nair Center for Personalized NanoMedicine, Institute of NeuroImmune Pharmacology, Department of Immunology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA Abstract: This viewpoint is a global call to promote fundamental and applied research aiming toward designing smart nanocarriers of desired properties, novel noninvasive strategies to open the blood–brain barrier (BBB), delivery/release of single/multiple therapeutic agents across the BBB to eradicate neurohuman immunodeficiency virus (HIV), strategies for on-demand site-specific release of antiretroviral therapy, developing novel nanoformulations capable to recognize and eradicate latently infected HIV reservoirs, and developing novel smart analytical diagnostic tools to detect and monitor HIV infection. Thus, investigation of novel nanoformulations, methodologies for site-specific delivery/release, analytical methods, and diagnostic tools would be of high significance to eradicate and monitor neuroacquired immunodeficiency syndrome. Overall, these developments will certainly help to develop personalized nanomedicines to cure HIV and to develop smart HIV-monitoring analytical systems for disease management. Keywords: nanotherapeutics, personalized nanomedicine, smart monitoring analytical systems, HIV disease management
format	article
author	Kaushik A Jayant RD Nair M
author_facet	Kaushik A Jayant RD Nair M
author_sort	Kaushik A
title	Advancements in nano-enabled therapeutics for neuroHIV management
title_short	Advancements in nano-enabled therapeutics for neuroHIV management
title_full	Advancements in nano-enabled therapeutics for neuroHIV management
title_fullStr	Advancements in nano-enabled therapeutics for neuroHIV management
title_full_unstemmed	Advancements in nano-enabled therapeutics for neuroHIV management
title_sort	advancements in nano-enabled therapeutics for neurohiv management
publisher	Dove Medical Press
publishDate	2016
url	https://doaj.org/article/9f66dc9ebf1c45208e52cf850ab7fd76
work_keys_str_mv	AT kaushika advancementsinnanoenabledtherapeuticsforneurohivmanagement AT jayantrd advancementsinnanoenabledtherapeuticsforneurohivmanagement AT nairm advancementsinnanoenabledtherapeuticsforneurohivmanagement
_version_	1718400610131247104

Advancements in nano-enabled therapeutics for neuroHIV management

Ejemplares similares